# FDA EIR - Boehringer Ingelheim Pharmaceuticals, Inc. - September 01, 2010

Source: https://www.globalkeysolutions.net/records/eir/boehringer-ingelheim-pharmaceuticals-inc/c2f00c08-0e01-4f3f-bbfa-5466b71914d6

> FDA EIR for Boehringer Ingelheim Pharmaceuticals, Inc. on September 01, 2010. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Boehringer Ingelheim Pharmaceuticals, Inc.
- Inspection Date: 2010-09-01
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2025-09-11](https://www.globalkeysolutions.net/records/483/boehringer-ingelheim-pharmaceuticals-inc/bc781480-aeee-407e-a25b-cb006433ea7d)

## Related Officers

- [company_representative](https://www.globalkeysolutions.net/people/steven-kuchenbrod/0a02f223-63d2-48b0-9266-dcb351ad01d6)
- [company_representative](https://www.globalkeysolutions.net/people/mark-lepkowski/0f67c7c5-8b86-41b6-ac0b-525d3b67e96f)
- [investigator](https://www.globalkeysolutions.net/people/sharon-k-gershon/2db55656-5600-42f6-8835-3e94a8e3b954)
- [company_representative](https://www.globalkeysolutions.net/people/linda-noffke/59112bc6-5638-4093-b2ff-dbc105181092)
- [company_representative](https://www.globalkeysolutions.net/people/gerd-reichert/64d40801-c2d1-4804-94c5-94ffaa8946d8)

Company: https://www.globalkeysolutions.net/companies/boehringer-ingelheim-pharmaceuticals-inc/437c28a1-054f-4c22-9dba-fd40af58a7be

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c